HuajuBiotechnology
We’re bringing our tissue-engineered blood vessels to the millions of patients who need them.
Tissue-Engineered Blood Vessels
From living cells engineered into a living vessel.
Our Approach
We grow human tissue in proprietary bioreactors.
Over a period of weeks, we engineer human cells to build their own structural matrix. We then render it invisible to the human body. What remains is a biomaterial the body accepts and integrates as its own. Scalable, consistent and ready for clinical acceleration.
See how it works →
Our Platform
Tissue-engineered grafts for the vessels that matter most.
Below 6mm, synthetic grafts struggle to keep small vessels open long-term.
Built on over 15 years of research, Huaju is proud to be delivering our tissue engineering platform to meet China’s rising clinical need for small diameter blood vessels.
We specialize in vascular grafts for dialysis access, coronary artery bypass grafting, peripheral artery bypass and vascular trauma.
Institutional Backing
Guangzhou Hi-tech Investment Group
Jihua Laboratory
Guangdong Provincial People's Hospital
South China University of Technology
National Program Support
Supported by the NMPA’s Chunyu Action initiative for accelerated medical innovation.